NCT01934556View on ClinicalTrials.gov

A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2018

Conditions

Diabetic Macular Edema

Interventions

DRUG

Ranibizumab 0.3 mg intravitreal injection

DEVICE

Guided Laser Photocoagulation

Trial Locations (3)

29169

Palmetto Retina Center, West Columbia

77030

Retina Consultants of Houston, Houston

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

All Listed Sponsors

lead

Palmetto Retina Center, LLC

OTHER

NCT01934556 - A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema | Biotech Hunter | Biotech Hunter